Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 16858-01-8, molcular formula is C18H18N4, introducing its new discovery. Formula: C18H18N4
The synthesis, characterization and exceptional activity of Cu I(TPMA)Br [TPMA = tris(2-pyridylmethyl)amine] and [Cu II(TPMA)Br][Br] complexes in ATRA reactions of polybrominated compounds to alkenes in the presence of reducing agent (AIBN) was reported. [CuII(TPMA)Br][Br], in conjunction with AIBN, effectively catalyzed ATRA reactions of CBr4 and CHBr3 to alkenes with concentrations between 5 and 100 ppm, which is the lowest number achieved in copper-mediated ATRA. The molecular structure of CuI(TPMA)Br indicated that the complex was pseudo-pentacoordinate in the solid state due to the coordination of TPMA [CuI-N: 2.1024(15), 2.0753(15), 2.0709(15) and 2.4397(14) A] and bromide anion to the copper(I) center [Cu I-Br 2.5088(3) A]. Variable temperature 1H NMR and cyclic voltammetry studies confirmed the equilibrium between Cu I(TPMA)Br and [CuI-(TPMA)(CH3CN)][Br], indicating some degree of halide anion dissociation in solution. The coordination of the bromide anion to the [CuI(TPMA)]+ cation resulted in a formation of much more reducing CuI(TPMA)Br complex (E1/2 = -720 mV vs. Fc/Fc+) than the corresponding ClO4- (E1/2 = -422 mV vs. Fc/Fc+) and PF6- (E1/2 = -421 mV vs. Fc/Fc+) analogues. In [CuII(TPMA)Br][Br], the CuII atom was coordinated by four nitrogen atoms [CuII-Neq 2.073(2) A and CuII-Nax 2.040(3) A] from TPMA ligand and a bromine atom [CuII-Br 2.3836(6) A]. The overall geometry of the complex was distorted trigonal bipyramidal. CuI(TPMA)Br and [CuII(TPMA)-Br][Br] complexes showed similar structural features from the point of view of TPMA coordination. The only more pronounced difference in the TPMA coordination to the copper center was observed in the shortening of Cu-Nax bond length by approximately 0.400 A on going from CuI(TPMA)Br to [CuII(TPMA)Br][Br]. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Formula: C18H18N4, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 16858-01-8
Reference:
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI